US FDA Staff Cite Risks with Acusphere Inc. Image Agent

December 8, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, Dec 8 (Reuters) - Safety risks with Acusphere Inc's Imagify may be "inappropriate" for use in diagnosing patients with heart problems, U.S. Food and Drug Administration staff said in documents released on Monday.

Twitter
LinkedIn
Facebook
Email
Print

Food and Drug Administration (FDA)